pharma
Stay on top of the latest hedge fund news with Hedge Fund Alpha! The investment world is always in motion, so it’s never been more important for investors to stay informed on what hedge funds are doing. We bring you timely, accurate reporting on top hedge funds like ValueAct, Citadel, Greenlight Capital, Third Point, Pabrai Investment Funds and more. Dive into the diverse perspectives presented by Hedge Fund Alpha and go behind the headlines here. Hedge Fund Alpha is your go-to source of hedge fund news. From breaking news to developing stories, we have our fingers on the pulse of the hedge fund community and investment universe. Check out all the top headlines here with Hedge Fund Alpha.
Nehal Chopra's Tiger Ratan Takes $300 Million Hit On Valeant Pharmaceuticals International Inc.
Nehal Chopra’s Tiger Ratan Takes $300 Million Hit On Valeant Pharmaceuticals International Inc.
Citron’s Last Word On Valeant Pharmaceuticals Intl (VRX)
Lakewood Capital Opens Shorts In Seagate, Diplomat Pharmacy, Ziopharm Oncology
Valeant Pharmaceuticals (VRX) Reflexive Behavior In Financial Markets: GS
What's Next For Valeant Pharmaceuticals (VRX)?
Valeant Pharmaceuticals (VRX) In Accounting Fraud: Citron
Valeant Pharmaceuticals (VRX) – Could This Be The Pharmaceutical Enron? Citron
Valeant Pharmaceuticals Under Fresh Scrutiny Over Drug Pricing
Keryx Biopharmaceuticals (KERX) Soars On Baupost Deal
Specialty Pharma, Generics M&A Frenzy To Continue Into 2016: Nomura
Specialty Pharma, Generics M&A Frenzy To Continue Into 2016: Nomura
Turing Pharmaceutical – Healthcare Cost Inflation: Cable Car
Baxalta Inc Set To Abandon Talks With Ariad Pharmaceuticals, Inc.
Gilead Sciences: Pharmaceutical Prices, Patents, And The FDA
Aquinox Pharmaceuticals (AQXP): Dumped By Big Pharmas
Bass Explains The Absurdity Of Horizon Pharma’s Vimovo Patent
Goldman Sachs – Pharma Versus Biotech Valuation
